Načítá se...
CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder
Gallbladder cancer is the most common biliary tract malignancy with the worst overall prognosis. CD109 is a co-receptor of TGF-β1 and suppresses TGF-β signaling. In this study, CD109 protein expression in three subtypes of gallbladder cancer was examined by immunohistochemistry on human tissue sampl...
Uloženo v:
| Vydáno v: | Diagn Pathol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4545819/ https://ncbi.nlm.nih.gov/pubmed/26249215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-015-0375-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|